TCL Archive Investigators Testing Ways To Overcome Gleevec Resistance: High Dose, New Drugs January 28, 2005
TCL Archive Phase III Trial Retrospective Analysis Finds Talimogene Laherparepvec Reduced Tumors March 28, 2014
TCL Archive DeVita Denies NCI Broke Faith With Communities On CHOP Awards, Says Total Of 30 “Not Absolute” August 15, 1980